Akebia Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Akebia Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $9.0k | 4.9k | 1.83 |
2023-12-31 | $6.1k | 4.9k | 1.24 |
2023-09-30 | $5.6k | 4.9k | 1.14 |
2023-06-30 | $4.5k | 4.9k | 0.91 |
2022-03-31 | $147k | 205k | 0.72 |
2021-12-31 | $477k | 211k | 2.26 |
2021-09-30 | $606k | 210k | 2.88 |
2021-06-30 | $769k | 203k | 3.79 |
2021-03-31 | $590k | 174k | 3.39 |
2020-12-31 | $529k | 189k | 2.80 |
2020-09-30 | $442k | 176k | 2.51 |
2020-06-30 | $2.8M | 209k | 13.58 |
2020-03-31 | $1.6M | 215k | 7.58 |
2019-12-31 | $1.2M | 184k | 6.32 |
2019-09-30 | $695k | 177k | 3.92 |
2019-06-30 | $780k | 161k | 4.84 |
2019-03-31 | $920k | 112k | 8.19 |
2018-12-31 | $671k | 121k | 5.53 |
2018-09-30 | $399k | 45k | 8.82 |
2018-06-30 | $476k | 48k | 9.99 |
2018-03-31 | $391k | 41k | 9.53 |
2017-12-31 | $606k | 41k | 14.86 |
2017-09-30 | $881k | 45k | 19.68 |
2017-06-30 | $596k | 42k | 14.36 |
2017-03-31 | $377k | 41k | 9.20 |
2016-12-31 | $414k | 40k | 10.42 |
2016-09-30 | $421k | 47k | 9.05 |
2016-06-30 | $343k | 46k | 7.48 |
2016-03-31 | $405k | 45k | 9.02 |
2015-12-31 | $424k | 33k | 12.93 |
2015-09-30 | $307k | 32k | 9.66 |
2015-06-30 | $308k | 30k | 10.29 |